Clinical Trial Update: Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Lactobacillus reuteri DSM 17938 for preventing antibiotic-associated diarrhea in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibiotic-associated Diarrhea

Drugs mentioned

• Lactobacillus reuteri DSM 17938 (Lactobacillus reuteri DSM 17938)

Snippet

Sponsor: Eskisehir Osmangazi University | Conditions: Antibiotic Associated Diarrhea | Phase 4 | Status: COMPLETED